INTERNATIONAL PATENT: HEIDELBERG PHARMA RESEARCH GMBH FILES APPLICATION FOR "ANTIBODY-DRUG CONJUGATE COMPRISING AN ANTI-GUCY2C ANTIBODY AS WELL AS METHODS OF PRODUCTION AND USES THEREOF"

GENEVA, June 16 -- HEIDELBERG PHARMA RESEARCH GMBH (Gregor-Mendel-Str. 2268526 Ladenburg) filed a patent application (PCT/EP2024/084933) for "ANTIBODY-DRUG CONJUGATE COMPRISING AN ANTI-GUCY2C ANTIBODY AS WELL AS METHODS OF PRODUCTION AND USES THEREOF" on Dec 05, 2024. With publication no. WO/2025/120090, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MULLER, Christoph (c/o Heidelberg Pharma Research GmbH, Gregor-Mendel-Str. 2268526 Ladenburg), GRUSS, Hendrik (c/o Heidelberg Pharma Research GmbH, Gregor-Mendel-Str. 226852...